13,728 reports of this reaction
4.7% of all MORPHINE SULFATE reports
#6 most reported adverse reaction
DRUG WITHDRAWAL SYNDROME is the #6 most commonly reported adverse reaction for MORPHINE SULFATE, manufactured by Rhodes Pharmaceuticals L.P.. There are 13,728 FDA adverse event reports linking MORPHINE SULFATE to DRUG WITHDRAWAL SYNDROME. This represents approximately 4.7% of all 294,935 adverse event reports for this drug.
MORPHINE SULFATE has an overall safety score of 92 out of 100. Patients taking MORPHINE SULFATE who experience drug withdrawal syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG WITHDRAWAL SYNDROME is moderately reported among MORPHINE SULFATE users, representing a notable but not dominant share of adverse events.
In addition to drug withdrawal syndrome, the following adverse reactions have been reported for MORPHINE SULFATE:
The following drugs have also been linked to drug withdrawal syndrome in FDA adverse event reports:
DRUG WITHDRAWAL SYNDROME has been reported as an adverse event in 13,728 FDA reports for MORPHINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG WITHDRAWAL SYNDROME accounts for approximately 4.7% of all adverse event reports for MORPHINE SULFATE, making it a notable side effect.
If you experience drug withdrawal syndrome while taking MORPHINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.